The purpose of this study is to assess the effects of ethinylestradiol 30µg-drospirenone
combined with metformin and weight loss by means of dietary intervention on the indices of
endothelial dysfunction (i.e. flow-mediated dilation and serum endothelin-1), serum
hsCRP,lipids,insulin resistance and body composition in young women with PCOS.